Monashee Investment Management LLC Eliem Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

  • $704 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$2.77 - $8.4 $629,346 - $1.91 Million
-227,201 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$8.01 - $13.15 $583,119 - $957,306
-72,799 Reduced 24.27%
227,201 $1.91 Million
Q4 2021

Feb 07, 2022
SELL
$8.61 - $20.47 $45,056 - $107,119
-5,233 Reduced 1.71%
300,000 $3.14 Million
Q3 2021

Nov 09, 2021
BUY
$14.45 - $28.61 $4.41 Million - $8.73 Million
305,233 New
305,233 $5.49 Million

Others Institutions Holding ELYM

# of Institutions
50
Shares Held
49.9M
Call Options Held
0
Put Options Held
0
View Full List

About Eliem Therapeutics, Inc.

ELYM Quotes by TradingView
  • Ticker ELYM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,567,700
  • Market Cap $109M
  • Description
  • Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...
More about ELYM
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email